Patient Death in Beam Sickle Cell Trial Attributed to Conditioning Regimen.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 328, doi. 10.1089/genbio.2024.0061
- By:
- Publication type:
- Article
Works matching IS 27681572 AND DT 2024 AND VI 3 AND IP 6
Results: 8
1
2
Measure for Measure.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
3
Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 325, doi. 10.1089/genbio.2024.0063
- By:
- Publication type:
- Article
4
A New Era of Mega Blockbusters: How Pharma is Being Redefined by Large-Scale Drug Development.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 335, doi. 10.1089/genbio.2024.0062
- By:
- Publication type:
- Article
5
Fauci Versus Viruses and Trump.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 333, doi. 10.1089/genbio.2024.0060
- By:
- Publication type:
- Article
6
Enhanced Quadruplet Suppression in E. coli for Expanding the Genetic Code.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 330, doi. 10.1089/genbio.2024.0058
- By:
- Publication type:
- Article
7
Real-Time Monitoring in Biomanufacturing with Graphene Field-Effect Transistor Sensors: Detection of pH, Glucose, and Antibodies.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 341, doi. 10.1089/genbio.2024.0043
- By:
- Publication type:
- Article
8
Beyond the Hype: The Reality of Implementing AI to Drive Drug Discovery Success.
- Published in:
- GEN Biotechnology, 2024, v. 3, n. 6, p. 338, doi. 10.1089/genbio.2024.0042
- By:
- Publication type:
- Article